GB9517022D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB9517022D0
GB9517022D0 GBGB9517022.1A GB9517022A GB9517022D0 GB 9517022 D0 GB9517022 D0 GB 9517022D0 GB 9517022 A GB9517022 A GB 9517022A GB 9517022 D0 GB9517022 D0 GB 9517022D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9517022.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9517022.1A priority Critical patent/GB9517022D0/en
Publication of GB9517022D0 publication Critical patent/GB9517022D0/en
Priority to AU69247/96A priority patent/AU6924796A/en
Priority to JP9508948A priority patent/JPH11512083A/en
Priority to PCT/EP1996/003601 priority patent/WO1997006804A1/en
Priority to ZA966969A priority patent/ZA966969B/en
Priority to EP96930043A priority patent/EP0844878A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
GBGB9517022.1A 1995-08-19 1995-08-19 Medicaments Pending GB9517022D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9517022.1A GB9517022D0 (en) 1995-08-19 1995-08-19 Medicaments
AU69247/96A AU6924796A (en) 1995-08-19 1996-08-16 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis c
JP9508948A JPH11512083A (en) 1995-08-19 1996-08-16 1,3-oxathiolane nucleoside analogs in the treatment of hepatitis C
PCT/EP1996/003601 WO1997006804A1 (en) 1995-08-19 1996-08-16 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis c
ZA966969A ZA966969B (en) 1995-08-19 1996-08-16 Medicaments
EP96930043A EP0844878A1 (en) 1995-08-19 1996-08-16 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis c

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9517022.1A GB9517022D0 (en) 1995-08-19 1995-08-19 Medicaments

Publications (1)

Publication Number Publication Date
GB9517022D0 true GB9517022D0 (en) 1995-10-25

Family

ID=10779487

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9517022.1A Pending GB9517022D0 (en) 1995-08-19 1995-08-19 Medicaments

Country Status (6)

Country Link
EP (1) EP0844878A1 (en)
JP (1) JPH11512083A (en)
AU (1) AU6924796A (en)
GB (1) GB9517022D0 (en)
WO (1) WO1997006804A1 (en)
ZA (1) ZA966969B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9605293D0 (en) * 1996-03-13 1996-05-15 Glaxo Group Ltd Medicaments
US6767991B1 (en) 1997-08-11 2004-07-27 Boehringer Ingelheim (Canada) Ltd. Hepatitis C inhibitor peptides
JP4452401B2 (en) * 1997-08-11 2010-04-21 ベーリンガー インゲルハイム （カナダ） リミテッド Hepatitis C virus inhibitory peptide analog
IL138037A0 (en) * 1998-02-25 2001-10-31 Univ Emory 2'-fluoronucleosides
US6323180B1 (en) * 1998-08-10 2001-11-27 Boehringer Ingelheim (Canada) Ltd Hepatitis C inhibitor tri-peptides
US6608027B1 (en) 1999-04-06 2003-08-19 Boehringer Ingelheim (Canada) Ltd Macrocyclic peptides active against the hepatitis C virus
GB9909154D0 (en) * 1999-04-22 1999-06-16 Nippon Glaxo Limited Pharmaceutical formulation
WO2001007027A2 (en) * 1999-07-22 2001-02-01 Vertex Pharmaceuticals Incorporated Pyrimidine derivatives for the treatment of viral diseases
US7244721B2 (en) 2000-07-21 2007-07-17 Schering Corporation Peptides as NS3-serine protease inhibitors of hepatitis C virus
MXPA03000626A (en) 2000-07-21 2004-07-30 Schering Corp Novel peptides as ns3-serine protease inhibitors of hepatitis c virus.
DE60141608D1 (en) 2000-07-21 2010-04-29 Dendreon Corp PEPTIDES AS INHIBITORS OF THE NS3 SERINE PROTEASE OF HEPATITIS C VIRUS
CN1646141B (en) * 2000-10-18 2014-06-25 吉利德制药有限责任公司 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
MY140680A (en) 2002-05-20 2010-01-15 Bristol Myers Squibb Co Hepatitis c virus inhibitors
DE60324552D1 (en) 2002-05-20 2008-12-18 Bristol Myers Squibb Co Substituierte cycloalkyl p1' hepatitis c virus inhibitoren
PL211889B1 (en) 2002-05-20 2012-07-31 Bristol Myers Squibb Co Heterocyclicsulfonamide hepatitis c virus inhibitors
AU2003299519A1 (en) 2002-05-20 2004-05-04 Bristol-Myers Squibb Company Hepatitis c virus inhibitors
EA009295B1 (en) 2003-05-21 2007-12-28 Бёрингер Ингельхайм Интернациональ Гмбх Hepatitis c inhibitor compounds
US20050058044A1 (en) * 2003-09-12 2005-03-17 Koegler John M. Optical disk modified for speed and orientation tracking
PE20050431A1 (en) 2003-09-22 2005-07-19 Boehringer Ingelheim Int MACROCYCLIC PEPTIDES ACTIVE AGAINST HEPATITIS C VIRUS
EA011857B8 (en) 2003-10-14 2012-08-30 Интермьюн, Инк. Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication
US7132504B2 (en) 2003-11-12 2006-11-07 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US7135462B2 (en) 2003-11-20 2006-11-14 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US7309708B2 (en) 2003-11-20 2007-12-18 Birstol-Myers Squibb Company Hepatitis C virus inhibitors
DE602005025855D1 (en) 2004-01-21 2011-02-24 Boehringer Ingelheim Pharma MACROCYCLIC PEPTIDES WITH EFFECT TO THE HEPATITIS C VIRUS
UY29016A1 (en) 2004-07-20 2006-02-24 Boehringer Ingelheim Int ANALOGS OF INHIBITING DIPEPTIDES OF HEPATITIS C
ES2366478T3 (en) 2004-07-20 2011-10-20 Boehringer Ingelheim International Gmbh PEPTIDE ANALOGS INHIBITORS OF HEPATITIS C.
AU2006276246B2 (en) 2005-07-25 2012-09-27 Intermune, Inc. Novel macrocyclic inhibitors of hepatitis C virus replication
UA93990C2 (en) 2005-10-11 2011-03-25 Интермюн, Инк. Compounds and methods for inhibiting hepatitis c viral replication
WO2007067364A2 (en) * 2005-12-02 2007-06-14 Yale University Methods of treating cancer and other conditions or disease states using l-cytosine nucleoside analogs
EA200971074A1 (en) 2007-06-29 2010-08-30 Джилид Сайэнс, Инк. ANTI-VIRUS CONNECTIONS
US8178491B2 (en) 2007-06-29 2012-05-15 Gilead Sciences, Inc. Antiviral compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int Pharmaceutical compositions containing cis-4-amino-1(hydroxymethyl-1,3-oxathiolan-5-yl)-1H-pyrimid-2-one nucleoside or its derivatives

Also Published As

Publication number Publication date
EP0844878A1 (en) 1998-06-03
ZA966969B (en) 1997-03-24
WO1997006804A1 (en) 1997-02-27
AU6924796A (en) 1997-03-12
JPH11512083A (en) 1999-10-19

Similar Documents

Publication Publication Date Title
HUP9801151A3 (en) Long-shelf-life medicaments
GB9517022D0 (en) Medicaments
GB9419536D0 (en) Medicaments
GB9406573D0 (en) Medicaments
GB9420784D0 (en) Medicaments
GB9526392D0 (en) Medicaments
GB9503850D0 (en) Medicaments
GB9418530D0 (en) Medicaments
GB9411052D0 (en) Medicaments
GB9421133D0 (en) Medicaments
GB9416365D0 (en) Medicaments
GB9523453D0 (en) Medicaments
GB9524173D0 (en) Medicaments
IL127776A0 (en) Medicaments
GB9506122D0 (en) Medicaments
GB9519021D0 (en) Medicaments
GB9521208D0 (en) Medicaments
GB9515628D0 (en) Medicaments
GB9504153D0 (en) Medicaments
GB9514723D0 (en) Medicaments
GB9517021D0 (en) Medicaments
GB9519029D0 (en) Medicaments
GB9519585D0 (en) Medicaments
GB9424013D0 (en) Medicaments
EP0790829A4 (en) Medicaments